A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23), Oncogene, vol.22, pp.5374-5378, 2003. ,
SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression, Genes & cancer, vol.1, pp.748-752, 2010. ,
Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study, BJU international, vol.97, pp.698-702, 2006. ,
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes, J Cell Biol, vol.142, pp.827-835, 1998. ,
URL : https://hal.archives-ouvertes.fr/inserm-02532974
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product, J Cell Biol, vol.134, pp.747-755, 1996. ,
URL : https://hal.archives-ouvertes.fr/inserm-02533106
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia, Mol Cell Biol, vol.18, pp.694-702, 1998. ,
URL : https://hal.archives-ouvertes.fr/inserm-02533084
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, vol.480, pp.94-98, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01791271
BRCA1 is a new MITF target gene, Pigment Cell Melanoma Res, vol.24, pp.725-727, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530733
Increased risk of second primary cancers after a diagnosis of melanoma, Arch Dermatol, vol.146, pp.265-272, 2010. ,
Genetic and environmental factors in cutaneous malignant melanoma, Biochimie, vol.84, pp.67-74, 2002. ,
Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells, J Cell Biol, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00321685
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness, Genes Dev, vol.20, pp.3426-3439, 2006. ,
Fifteen-year quest for microphthalmia-associated transcription factor target genes, Pigment Cell Melanoma Res, vol.23, pp.27-40, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530740
Cellular senescence in cancer and aging, Cell, vol.130, pp.223-233, 2007. ,
Frequent mutations in the MITF pathway in melanoma, Pigment Cell Melanoma Res, vol.22, pp.435-444, 2009. ,
Mutations of the BRAF gene in human cancer, Nature, vol.417, pp.949-954, 2002. ,
MiT transcription factor associated malignancies in man, Cell Cycle, vol.6, pp.1724-1729, 2007. ,
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation, Proc Natl Acad Sci U S A, vol.100, pp.6051-6056, 2003. ,
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers, Cancer Cell, vol.9, pp.473-484, 2006. ,
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis, Eur J Cancer, vol.46, pp.1413-1420, 2010. ,
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, vol.436, pp.117-122, 2005. ,
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history, Pigment Cell Melanoma Res, vol.26, pp.259-262, 2013. ,
Functional profiling of the Saccharomyces cerevisiae genome, Nature, vol.418, pp.387-391, 2002. ,
Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas, Cancer Res, vol.70, pp.3813-3822, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530789
Advances in melanoma senescence and potential clinical application. Pigment Cell Melanoma Res In press, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530650
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011. ,
Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF, Development, vol.127, pp.5379-5389, 2000. ,
Germline p16 mutations in familial melanoma, Nat Genet, vol.8, pp.15-21, 1994. ,
Expression of sumoylation deficient Nkx2.5 mutant in Nkx2.5 haploinsufficient mice leads to congenital heart defects, J Invest Dermatol, vol.6, pp.1763-1774, 2011. ,
Molecular diagnosis and therapy of kidney cancer, Annual review of medicine, vol.61, pp.329-343, 2010. ,
Characteristics of the coexistence of melanoma and renal cell carcinoma, Cancer, vol.116, pp.5716-5724, 2010. ,
Sumoylation of MITF and its related family members TFE3 and TFEB, J Biol Chem, vol.280, pp.146-155, 2005. ,
A role for Ubc9 in tumorigenesis, Oncogene, vol.24, pp.2677-2683, 2005. ,
The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress, Nature, vol.462, pp.886-890, 2009. ,
Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner, Pigment Cell Res, vol.18, pp.265-277, 2005. ,
The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice, Dev Cell, vol.9, pp.769-779, 2005. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02075525
Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche, Science, 2004. ,
Review and update of mutations causing Waardenburg syndrome, Hum Mutat, vol.31, pp.391-406, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00483195
SUMO and its role in human diseases, International review of cell and molecular biology, vol.288, pp.167-183, 2011. ,
Risk of second primary malignancies in patients with cutaneous melanoma, Br J Dermatol, vol.145, pp.981-985, 2001. ,
Apoptosis and melanoma chemoresistance, Oncogene, vol.22, pp.3138-3151, 2003. ,
Melanocytes and the microphthalmia transcription factor network, Annu Rev Genet, vol.38, pp.365-411, 2004. ,
Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development, In Proc Natl Acad Sci, pp.4477-4482, 2002. ,
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma, Oncogene, vol.30, pp.2319-2332, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530755
Phenotypic Characterization of Nevus and Tumor Patterns in MITF E318K Mutation Carrier Melanoma Patients, J Invest Dermatol, 2013. ,
TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition, Cancer Res, vol.67, pp.919-929, 2007. ,
SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence, Cell Death Differ, vol.18, pp.304-314, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00570132
Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins, Oncogene, vol.19, pp.69-74, 2000. ,
Mechanisms, regulation and consequences of protein SUMOylation, Biochem J, vol.428, pp.133-145, 2010. ,
The association between malignant melanoma and noncutaneous malignancies, International journal of dermatology, vol.45, pp.529-534, 2006. ,
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, vol.480, pp.99-103, 2011. ,
Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies, J Cell Biol, vol.182, pp.35-39, 2008. ,
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma, Nat Genet, vol.12, pp.97-99, 1996. ,